首页|依诺肝素钠联合拉贝洛尔治疗对妊娠期高血压疾病孕妇子宫动脉血流及内皮功能的影响

依诺肝素钠联合拉贝洛尔治疗对妊娠期高血压疾病孕妇子宫动脉血流及内皮功能的影响

扫码查看
目的 分析依诺肝素钠联合拉贝洛尔治疗对妊娠期高血压疾病(HDP)孕妇子宫动脉血流及内皮功能的影响。方法 98 例HDP孕妇,以随机数字表法将其分为对照组和研究组,每组 49 例。两组均接受常规对症治疗,在此基础上,对照组采用拉贝洛尔治疗,研究组采用依诺肝素钠联合拉贝洛尔治疗。对比两组治疗前后血压水平、子宫动脉血流指标、血管内皮功能及治疗效果。结果 治疗 2 周后,两组收缩压及舒张压水平均较治疗前降低,且研究组收缩压(120。39±6。08)mm Hg(1 mm Hg=0。133 kPa)、舒张压(83。32±3。49)mm Hg均低于对照组的(129。75±6。30)、(86。58±3。21)mm Hg(P<0。05)。治疗 2 周后,两组血流搏动指数(PI)、血流阻力指数(RI)均较治疗前降低,且研究组PI(0。79±0。10)、RI(0。42±0。05)均低于对照组的(0。85±0。11)、(0。49±0。07)(P<0。05)。治疗 2 周后,两组一氧化氮较治疗前升高,内皮素较治疗前降低,且研究组内皮素(35。34±12。25)ng/L低于对照组的(48。63±14。19)ng/L、一氧化氮(51。29±5。23)μmol/L高于对照组的(40。81±5。16)μmol/L(P<0。05)。研究组治疗总有效率 95。92%高于对照组的 83。67%(P<0。05)。结论 HDP采用拉贝洛尔联合依诺肝素钠辅助治疗,改善了孕妇子宫动脉血流情况及血管内皮功能,疗效显著。
Effect of enoxaparin sodium combined with labetalol on uterine artery blood flow and endothelial function in pregnant women with hypertensive disorders of pregnancy
Objective To analyze the effect of enoxaparin sodium combined with labetalol on uterine artery blood flow and endothelial function in pregnant women with hypertensive disorders of pregnancy(HDP).Methods 98 women with HDP were divided into a control group and a study group by random number table method,each consisting 49 cases.Both groups received conventional symptomatic treatment.On this basis,the control group was treated with labetalol,and the study group was treated with enoxaparin sodium combined with labetalol.The blood pressure level,uterine artery blood flow index,vascular endothelial function and therapeutic effect before and after treatment were compared between the two groups.Results After 2 weeks of treatment,the systolic and diastolic blood pressure levels in both groups were lower than those before treatment;the study group had systolic blood pressure of(120.39±6.08)mm Hg(1 mm Hg=0.133 kPa)and diastolic blood pressure of(83.32±3.49)mm Hg,which were lower than(129.75±6.30)and(86.58±3.21)mm Hg in the control group(P<0.05).After 2 weeks of treatment,the pulsatility index(PI)and resistance index(RI)in both groups were lower than those before treatment;the study group had PI of(0.79±0.10)and RI of(0.42±0.05),which were lower than(0.85±0.11)and(0.49±0.07)in the control group(P<0.05).After 2 weeks of treatment,the nitric oxide increased and endothelin decreased in both groups compared with those before treatment;the endothelin level of(35.34±12.25)ng/L in the study group was lower than(48.63±14.19)ng/L in the control group,and the nitric oxide level of(51.29±5.23)μmol/L was higher than(40.81±5.16)μmol/L in the control group(P<0.05).The total effective rate of treatment in the study group was 95.92%,which was higher than 83.67%in the control group(P<0.05).Conclusion Labetalol combined with enoxaparin sodium for HDP can improve uterine artery blood flow and vascular endothelial function of patients,and the efficacy is significant.

Enoxaparin sodiumHypertensive disorders of pregnancyUterine artery blood flowEndothelial function

樊小艳、易秋红、李霞青

展开 >

330000 江西省妇幼保健院产科

依诺肝素钠 妊娠期高血压疾病 子宫动脉血流 血管内皮功能

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(24)